AVCRAvricore Health Inc.

TSXV · CA · Healthcare · Diagnostics & Research · avricore.com

0.0650CAD+18.18%Mkt Cap: 5.98M $P/E: —3d ago

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap5.98M $

Enterprise Value5.01M $

Revenue (TTM)104.97K $

Gross Profit173.54K $

Net Income (TTM)-1.35M $

Revenue/Share0.0007 USD

Last Price0.0650 CAD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-5.32

EV/Revenue47.73

P/S61.37

P/B35.00

EPS (TTM)-0.02

EPS (Forward)—

52W Range

0.045036% of range0.1000

52W High0.1000 CAD

52W Low0.0450 CAD

Profitability

Gross Margin44.63%

Oper. Margin-532.57%

EBITDA Margin0.00%

Profit Margin-348.16%

ROE-477.14%

ROA-330.08%

Growth

Revenue Growth-89.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-575.28K $

CapEx (TTM)83.29K $

FCF Margin-311.49%

FCF Yield-5.47%

Net Debt-153.15K $

Net Debt/EBITDA0.16

Balance Sheet

Debt/Equity—

Current Ratio1.03

Quick Ratio0.68

Book Value/Sh0.0020 CAD

Cash/Share0.0020 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateNov 21, 2016

Splits

Last Split1:4

Split DateNov 21, 2016

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.126.37M

Float91.90M

Insiders7.95%

Institutions0.00%

Short Interest

Short Ratio0.0d

Short % Float0.00%

Short % Out.0.00%

Shares Short1.08K

Short (prev mo.)8.87K

Technical

SMA 500.0561 (+15.9%)

SMA 2000.0614 (+5.9%)

Beta0.32

S&P 52W Chg18.16%

Avg Vol (30d)33.12K

Avg Vol (10d)52.01K

Technical Indicators

RSI (14)62.2

MACD0.0001

MACD Signal-0.0006

MACD Hist.+0.0007

BB Upper0.0672 CAD

BB Middle0.0568 CAD

BB Lower0.0464 CAD

BB Width36.65%

ATR (14)0.0041 CAD

Vol Ratio (20d)0.84x